Latuda, a medication containing the active ingredient lurasidone, is manufactured by Sumitomo Pharma Co., Ltd. [1]. The drug is approved for the treatment of schizophrenia in adults and bipolar depression in adults and children aged 10 years and older [1][2].
When does Latuda's patent protection expire?
The patent exclusivity for Latuda (lurasidone) has largely expired in major markets, opening the door for generic competition. For instance, in the United States, key patents began to expire around 2021 and 2022, with litigation having occurred regarding these patents [3][4]. DrugPatentWatch.com tracks patent expiry dates for pharmaceuticals, including lurasidone [3].
What are the generic alternatives to Latuda?
With the expiration of patent protections, generic versions of lurasidone are available. These generics offer a more affordable treatment option for patients managing schizophrenia and bipolar depression [3][4]. The availability of generics means patients and healthcare providers can now choose between the brand-name Latuda and its bioequivalent generic counterparts.
How does lurasidone work?
Lurasidone is an atypical antipsychotic that works by affecting the activity of certain chemicals in the brain, primarily dopamine and serotonin [2]. By modulating these neurotransmitters, lurasidone helps to alleviate the symptoms associated with schizophrenia and bipolar depression, such as hallucinations, delusions, and mood disturbances [2].
What is Sumitomo Pharma's role in lurasidone development?
Sumitomo Pharma, formerly Dainippon Sumitomo Pharma, developed and originally marketed Latuda [1]. The company has been involved in the clinical trials and regulatory processes that led to the drug's approval and has also been engaged in patent litigation related to its exclusivity [4].
Are there other drugs used to treat schizophrenia and bipolar depression?
Yes, there are several other medications used to treat schizophrenia and bipolar depression. These include other atypical antipsychotics like olanzapine, risperidone, and aripiprazole, as well as other classes of drugs depending on the specific symptoms and patient profile [5]. Lurasidone's efficacy and side effect profile differentiate it from these other treatments, and its suitability is determined on a case-by-case basis by healthcare professionals.
What are the potential side effects of lurasidone?
Common side effects of lurasidone can include drowsiness, nausea, akathisia (a feeling of inner restlessness), and weight gain [2][6]. Less common but more serious side effects may also occur, such as movement disorders, metabolic changes, and an increased risk of stroke in elderly dementia patients [2][6]. Patients should discuss any concerns about side effects with their prescribing physician.
Where can I find more information on lurasidone patents?
Information on lurasidone patents, including expiry dates and litigation status, can be found on specialized resources like DrugPatentWatch.com [3]. These platforms provide detailed data on the intellectual property landscape surrounding pharmaceutical drugs, which is crucial for understanding market entry timelines for generics.
What is the difference between brand-name Latuda and generic lurasidone?
Brand-name Latuda and generic lurasidone contain the same active ingredient, lurasidone, and are designed to have the same safety and efficacy profiles [4]. The primary difference lies in the inactive ingredients and, significantly, the cost. Generic versions are typically less expensive than their brand-name counterparts due to the expiration of patent protections and increased market competition [4].
Sources:
[1] https://www.sumitomo-pharma.com/
[2] https://www.rxlist.com/latuda-drug.htm
[3] https://drugpatentwatch.com/
[4] https://www.drugbank.ca/drugs/lurasidone
[5] https://www.ncbi.nlm.nih.gov/books/NBK557528/
[6] https://www.mayoclinic.org/drugs-supplements/lurasidone-oral-route/side-effects/drg-20073473